Indian Journal of Urology
: 2006  |  Volume : 22  |  Issue : 3  |  Page : 188--193

Minimally invasive treatments for benign prostatic hyperplasia

Brian A VanderBrink, Gopal H Badlani 
 Department of Urology, Long Island Jewish Medical Center, New Hyde Park, New York, USA

Correspondence Address:
Gopal H Badlani
North Shore-Long Island Jewish Health System, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040

Minimally invasive treatment (MIT) options for relief of symptoms attributed to benign prostatic obstruction (BPO) are becoming a more commonly used option for patients failing medical therapy. These MIT utilize an endoscopic approach to either ablate the obstructing prostatic tissue by a variety of techniques or to place a urethral stent to relieve BPO. The uniting factor in all MIT is to decrease or eliminate the current morbidity and complications that accompany the standard surgical therapy such as transurethral resection of prostate (TURP). Clinical trials evaluating the efficacy and morbidity of these MIT modalities, either alone or in comparison to TURP are reviewed. Level I evidence (randomized controlled trials) are present for most of the MITs and provide the strongest support for overall conclusions. Symptomatic improvements and quality of life (QoL) improvements for all of the MIT follow a similar pattern with a more pronounced improvement in outcomes for the more ablative techniques. Uroflowmetry and durability of outcomes, however, seem to demonstrate little differences amongst the therapies. Disparities existed in the morbidity observed with the different techniques. Urinary retention and urinary infections were more common in the ablative technologies. Rates of blood loss, urinary incontinence, sexual dysfunction and urethral strictures were observed at a lower rate in the MIT groups when compared to the rates observed in TURP. The morbidity and durability of TURP is higher and longer than that of MIT, respectively.

How to cite this article:
VanderBrink BA, Badlani GH. Minimally invasive treatments for benign prostatic hyperplasia.Indian J Urol 2006;22:188-193

How to cite this URL:
VanderBrink BA, Badlani GH. Minimally invasive treatments for benign prostatic hyperplasia. Indian J Urol [serial online] 2006 [cited 2022 Jan 16 ];22:188-193
Available from:;year=2006;volume=22;issue=3;spage=188;epage=193;aulast=VanderBrink;type=0